Helsinki-based developer of non-invasive brain stimulation devices and therapies using transcranial direct current stimulation.
Founded in 2013 and based in Helsinki, Finland, Sooma Oy makes tDCS therapy devices for treating major depressive disorder and chronic pain conditions such as fibromyalgia and chronic neuropathic pain. Its Sooma Duo is described as the first EU MDR-certified tDCS system, with remote monitoring for clinicians. Venture funding was led by M&M Growth Partners, and as of August 2024 the therapies were used in over 35 countries, under CEO Tuomas Neuvonen.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in